Correlation Between GeneReach Biotechnology and LandMark Optoelectronics

Can any of the company-specific risk be diversified away by investing in both GeneReach Biotechnology and LandMark Optoelectronics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GeneReach Biotechnology and LandMark Optoelectronics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between GeneReach Biotechnology and LandMark Optoelectronics, you can compare the effects of market volatilities on GeneReach Biotechnology and LandMark Optoelectronics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GeneReach Biotechnology with a short position of LandMark Optoelectronics. Check out your portfolio center. Please also check ongoing floating volatility patterns of GeneReach Biotechnology and LandMark Optoelectronics.

Diversification Opportunities for GeneReach Biotechnology and LandMark Optoelectronics

-0.84

Correlation Coefficient

GeneReach Biotechnology  LandMark Optoelectronics

Pay attention - limited upside

The 3 months correlation between GeneReach and LandMark is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding GeneReach Biotechnology and LandMark Optoelectronics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LandMark Optoelectronics and GeneReach Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GeneReach Biotechnology are associated (or correlated) with LandMark Optoelectronics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LandMark Optoelectronics has no effect on the direction of GeneReach Biotechnology i.e., GeneReach Biotechnology and LandMark Optoelectronics go up and down completely randomly.

Pair Corralation between GeneReach Biotechnology and LandMark Optoelectronics

Assuming the 90 days trading horizon GeneReach Biotechnology is expected to under-perform the LandMark Optoelectronics. But the stock apears to be less risky and, when comparing its historical volatility, GeneReach Biotechnology is 4.26 times less risky than LandMark Optoelectronics. The stock trades about -0.2 of its potential returns per unit of risk. The LandMark Optoelectronics is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest  19,450  in LandMark Optoelectronics on September 3, 2024 and sell it today you would earn a total of  14,850  from holding LandMark Optoelectronics or generate 76.35% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

GeneReach Biotechnology  vs.  LandMark Optoelectronics

GeneReach Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days GeneReach Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

LandMark Optoelectronics

Risk-Adjusted Performance

16 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in LandMark Optoelectronics are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, LandMark Optoelectronics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with GeneReach Biotechnology and LandMark Optoelectronics

The main advantage of trading using opposite GeneReach Biotechnology and LandMark Optoelectronics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GeneReach Biotechnology position performs unexpectedly, LandMark Optoelectronics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LandMark Optoelectronics will offset losses from the drop in LandMark Optoelectronics' long position.

The idea behind GeneReach Biotechnology and LandMark Optoelectronics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..